Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
X
XBI
State Street SPDR S&P Biotech ETF
136.2
0
USD
+9917.65%
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+9917.65%
Monthly Change
+5.17%
6 month change
+11.88%
Year Change
+23.67%
Previous Close
1.3
6
Open
136.4
8
Low
136.1
5
High
136.7
3
Volume
649
Markets
US ETFs
XBI
Open full chart
Full chart
Overview
All holdings
Heatmap
Top holdings
Market Value
Shares
Weight %
MYGN
Myriad Genetics Inc
15.2 M
2.5 M
0.2%
IMRX
Immuneering Corp
14.3 M
2.2 M
0.2%
RGNX
REGENXBIO Inc
14.1 M
980.9 K
0.2%
CMPX
Compass Therapeutics Inc
13.5 M
2.5 M
0.2%
VIR
Vir Biotechnology Inc
13.4 M
2.2 M
0.2%
AKBA
Akebia Therapeutics Inc
13.3 M
8.3 M
0.2%
PRTA
Prothena Corp PLC
13.1 M
1.4 M
0.2%
CRVS
Corvus Pharmaceuticals Inc
12.7 M
1.7 M
0.2%
ABSI
Absci Corp
11.8 M
3.4 M
0.2%
ANNX
Annexon Inc
11.8 M
2.3 M
0.2%
ALT
Altimmune Inc
11.7 M
3.2 M
0.1%
IVVD
Invivyd Inc
11.6 M
4.7 M
0.1%
INBX
Inhibrx Biosciences Inc
11.2 M
142.2 K
0.1%
PRME
Prime Medicine Inc
10.8 M
3.1 M
0.1%
CGEM
Cullinan Therapeutics Inc
10.6 M
1.0 M
0.1%
FDMT
4D Molecular Therapeutics Inc
10.4 M
1.4 M
0.1%
KROS
Keros Therapeutics Inc
10.2 M
501.7 K
0.1%
AVBP
ArriVent Biopharma Inc
9.6 M
478.4 K
0.1%
ABUS
Arbutus Biopharma Corp
9.3 M
1.9 M
0.1%
AVXL
Anavex Life Sciences Corp
9.2 M
2.6 M
0.1%
1
2
3
4
5
6
7
8
News
First Quarter Earnings: Sharpening Sector Divergence
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Biotech Investors Are Tuning Out the MAHA Chaos
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI)
FDA Commissioner Marty Makary Expected To Resign, Ending Turbulent Stint
Why I Now Favor A Barbell Model Over Ray Dalio’s All-Weather Portfolio (SPY)
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy Zone
Broadcom, Google And Caterpillar Lead AI Charge On Must-See List